Trial-Ready Cohort-Down Syndrome (TRC-DS)
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- University of Southern California
- Study ID
- NCT04165109
- Status
- Recruiting
Conditions
- Alzheimer Disease
- Dementia
- Down Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 25 Years - 55 Years
- Healthy Volunteers
- Not accepted
Study Details
The purpose of the Trial-Ready Cohort - Down Syndrome (TRC-DS) is to enroll 120 healthy adults with Down syndrome (DS), between the ages of 25-55, into a trial ready cohort (TRC), and up to 550 participants in total including co-enrolled in the Alzheimer Biomarkers Consortium - Down Syndrome (ABC-DS) study. Participants enrolled in the TRC-DS will undergo longitudinal cognitive and clinical assessment, genetic and biomarker testing, as well as imaging and biospecimen collection. Using these outcome measures, researchers will analyze the relationships between cognitive measures and biomarkers of Alzheimer's disease (AD) to identify endpoints for AD clinical trials in DS that best reflect disease progression. To learn more about the study and participating sites, visit our study website at: https://www.trcds.org/. TRC-DS is collaborating with the Alzheimer's Disease Biomarker Consortium-Down Syndrome (ABC-DS) to allow study participants to be concurrently enrolled in both ABC-DS and TRC-DS, referred to as "co-enrollment". ABC-DS is a longitudinal, observational research study that is overseen at University of Pittsburgh Coordinating Center. ABC-DS participants who express interest in potentially joining a clinical trial in the future and who meet TRC-DS eligibility criteria, may choose to co-enroll in TRC-DS at an ABC-DS Site. Co-enrolled participants will adhere to the ABC-DS protocol and schedule of activities, but agree to share their data with the TRC-DS team and to receive invitations for future participation in clinical trials. Fore more information on ABC-DS please visit https://www.nia.nih.gov/research/abc-ds or http://abcds.pitt.edu/.
Key Dates
- Start date
- Jun 7, 2021
- Status verified
- May 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 550 participants (estimated)
Arms
- Arm: Trial Ready CohortNon-demented adults with Down syndrome (DS)
Primary Outcome Measure
Enrollment of participants into the Trial-Ready Cohort in DS (TRC-DS). [ Time Frame: 5 years ]
Central Contacts
- ATRI Recruitment Team213-821-0569
Locations (18)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Barrow Neurological Institute | Phoenix | Arizona | 85013 | Anna Burke, MD (PRINCIPAL_INVESTIGATOR) |
| University of California, Irvine School of Medicine, Co-Enrolling through ABC-DS Only | Orange | California | 92868 | Ira Lott (PRINCIPAL_INVESTIGATOR) |
| Linda Crnic Institute for Down Syndrome, University of Colorado | Aurora | Colorado | 80045 | Joaquin Espinosa, PhD (PRINCIPAL_INVESTIGATOR) |
| Advocate Medical Group Adult Down Syndrome Center | Park Ridge | Illinois | 60068 | Brian Chicoine, MD (PRINCIPAL_INVESTIGATOR) |
| Indiana University | Indianapolis | Indiana | 46202 | Jill Fodstad, PhD (PRINCIPAL_INVESTIGATOR) |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | Lauren T Ptomey, PhD, RD, LD (PRINCIPAL_INVESTIGATOR) |
| University of Kentucky, Co-Enrolling through ABC-DS Only | Lexington | Kentucky | 40504 | Frederick Schmitt, PhD (PRINCIPAL_INVESTIGATOR) |
| Massachusetts General Hospital, Co-Enrolling through ABC-DS Only | Boston | Massachusetts | 02114 | Herminia Herminia Diana Rosas (PRINCIPAL_INVESTIGATOR) |
| Washington University, St. Louis | St Louis | Missouri | 63108 | Beau Ances, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| Cleveland Clinic, Lou Ruvo Center for Brain Health, Las Vegas | Las Vegas | Nevada | 89106 | Charles Bernick, MD (PRINCIPAL_INVESTIGATOR) |
| New York State Institute for Basic Research in Developmental Disabilities (SIBRDD), Co-Enrolling through ABC-DS Only | Staten Island | New York | 10314 | Sharon Krinsky-McHale, PhD (PRINCIPAL_INVESTIGATOR) |
| Case Western Reserve University | Beachwood | Ohio | 44122 | Rajeet Shrestha, MD (PRINCIPAL_INVESTIGATOR) |
| University of Cincinnati | Cincinnati | Ohio | 45219 | Russell Sawyer, MD (PRINCIPAL_INVESTIGATOR) |
| Oregon Health & Science University | Portland | Oregon | 97239 | Aimee Pierce, MD (PRINCIPAL_INVESTIGATOR) |
| University of Pittsburgh, Co-Enrolling through ABC-DS Only | Pittsburgh | Pennsylvania | 15213 | Benjamin Handen (PRINCIPAL_INVESTIGATOR) |
| Vanderbilt University Medical Center Center for Cognitive Medicine | Nashville | Tennessee | 37212 | Paul Newhouse, MD (PRINCIPAL_INVESTIGATOR) |
| University of Texas Health San Antonio, Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases | San Antonio | Texas | 78229 | Sarah Savoia, PAC-C (PRINCIPAL_INVESTIGATOR) |
| University of Wisconsin - Madison, Waisman Center, Co-Enrolling through ABC-DS Only | Madison | Wisconsin | 53705 | Bradley Christian (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Phoenix, AZ
Related Studies
- Alzheimer's Disease Genetics StudyRecruiting · Indiana University · Nationwide, Indiana
- Specimen Collection from Pregnant Women At Increased Risk for Fetal AneuploidyRecruiting · Sequenom, Inc. · Birmingham, Alabama
- Computer Models of Airways in Children and Young Adults With Sleep Apnea and Down SyndromeEnrolling By Invitation · Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio
- DS-Connect®: The Down Syndrome RegistryRecruiting · University of Colorado, Denver · Aurora, Colorado